About Baxano Surgical (OTCMKTS:BAXSQ)
Baxano Surgical, Inc., formerly Baxano Inc. is a medical device company. The Company is focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region. The Company markets the AxiaLIF pre-sacral access and interbody fusion system for single and two level lower lumbar fusion, the VEO lateral access and interbody fusion system, the iO-Flex set of flexible instruments used by surgeons during spinal decompression procedures, and the iO-Tome instrument for rapid and precise removal of bone, specifically the facet joints, a technique which is commonly performed in spinal fusion procedures. The Company’s other products include: Vectre facet screw system, Bi-Ostetic bone void filler, bowel retractors, discectomy tools, and a bone graft harvesting system that can be used to extract bone graft from the patient’s hip for use in fusion procedures.
Industry, Sector and Symbol
Trailing P/E Ratio-0.00588235294117647
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity-117.23%
Return on Assets-56.63%
Baxano Surgical (OTCMKTS:BAXSQ) Frequently Asked Questions
What is Baxano Surgical's stock symbol?
Baxano Surgical trades on the OTCMKTS under the ticker symbol "BAXSQ."
How were Baxano Surgical's earnings last quarter?
Baxano Surgical Inc (OTCMKTS:BAXSQ) released its earnings results on Tuesday, August, 5th. The medical device company reported ($0.18) earnings per share for the quarter, missing analysts' consensus estimates of ($0.14) by $0.04. Baxano Surgical had a negative return on equity of 117.23% and a negative net margin of 126.01%. View Baxano Surgical's Earnings History.
Who are some of Baxano Surgical's key competitors?
Some companies that are related to Baxano Surgical include Savient Pharmaceuticals (SVNTQ), NephroGenex (NRXGQ), Air Methods (AIRM), Alexza Pharmaceuticals (ALXA), Allos Therapeutics (ALTH), Ambit Biosciences (AMBI), Amgen Rockville (MITI), Amylin Pharmaceuticals (AMLN), Ardea Biosciences (RDEA), Ariad Pharmaceuticals (ARIA), ArthroCare (ARTC), Asante Solutions (PUMP), Avanir Pharmaceuticals (AVNR), Baxalta (BXLT), Bayer Essure (CPTS), BioMimetic Therapeutics (BMTI), Bio-Reference Laboratories (BRLI) and Cadence Pharmaceuticals (CADX).
How do I buy Baxano Surgical stock?
Shares of Baxano Surgical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Baxano Surgical's stock price today?
One share of Baxano Surgical stock can currently be purchased for approximately $0.00.
How big of a company is Baxano Surgical?
Baxano Surgical has a market capitalization of $149,180.00.
How can I contact Baxano Surgical?
Baxano Surgical's mailing address is 110 Horizon Dr Ste 230, RALEIGH, NC 27615-4927, United States. The medical device company can be reached via phone at +1-919-8000020.
MarketBeat Community Rating for Baxano Surgical (BAXSQ)MarketBeat's community ratings are surveys of what our community members think about Baxano Surgical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Baxano Surgical (OTCMKTS:BAXSQ) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Baxano Surgical (OTCMKTS:BAXSQ) Earnings History and Estimates Chart
Baxano Surgical (OTCMKTS BAXSQ) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/8/2013||Q2 2013||($0.14)||($0.21)||$6.90 million||$3.90 million||View||N/A|
|3/4/2013||Q4 2012||($0.20)||($0.20)||$3.82 million||$4.10 million||View||N/A|
|11/8/2012||Q312||($0.16)||($0.22)||$4.70 million||$3.20 million||View||N/A|
Baxano Surgical (OTCMKTS:BAXSQ) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Baxano Surgical (OTCMKTS:BAXSQ)
No dividend announcements for this company have been tracked by MarketBeat.com
Baxano Surgical (OTCMKTS BAXSQ) Insider Trading and Institutional Ownership History
Baxano Surgical (OTCMKTS BAXSQ) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|8/15/2014||Kenneth Michael Reali||CEO||Buy||10,000||$0.38||$3,800.00|| |
|5/12/2014||Kenneth Michael Reali||CEO||Buy||7,050||$0.71||$5,005.50|| |
|12/5/2013||Kenneth Michael Reali||CEO||Buy||10,500||$1.11||$11,655.00|| |
|5/31/2013||Roderick A Young||Director||Buy||1,340,034||$2.28||$3,055,277.52|| |
Baxano Surgical (OTCMKTS BAXSQ) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Baxano Surgical (OTCMKTS:BAXSQ) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Baxano Surgical (OTCMKTS BAXSQ) Stock Chart for Thursday, January, 18, 2018